Questions and answers

Stage 4 cancer: what it means, treatment and life expectancy

What stage 4 means, how it differs from stage 3, whether it is always "the end of the road", the goals of treatment and how much life expectancy differs between cancers

Updated: 28 October 20266 min read14 references
Show content for:
Short answer

Stage 4, or "stage IV", means that the cancer has spread from where it started to distant parts of the body, such as the liver, lungs, bones or brain [1, 2]. Most stage 4 cancers can be treated: the goal of treatment is often to stop or slow the cancer and to improve quality of life, and some people live for years with cancer that is well controlled [2]. A few cancers, such as testicular cancer and Hodgkin lymphoma, are cured most of the time even when they have spread [4, 5].

Key points

  • Stage 4 is the same as cancer that has spread (metastatic cancer), and it keeps the name of the original cancer: breast cancer that has spread to the lungs is stage 4 breast cancer, not lung cancer [2].
  • Stage 4 is not always the end of the road: in the United States, the number of people who live for 5 years with cancer that has spread has almost doubled since the 1990s [3].
  • Life expectancy at stage 4 differs greatly with the type of cancer and the genetic features of the tumour; with targeted drugs and immunotherapy, many patients live for years [7, 8, 9].
  • Ask for palliative care (control of pain and other symptoms) from the start, alongside cancer treatment; in one study, patients' quality of life improved and they even lived longer [10].

What does stage 4 cancer mean?

Doctors use the "stage" to describe how large a cancer is and how far it has reached. Stage 0 means that abnormal cells have not yet spread into nearby tissue; in stages 1 to 3 cancer is present, and the higher the number, the larger the tumour and the further it has spread into nearby tissues; and stage 4 means that the cancer has spread to distant parts of the body [1]. In medical reports, this is also shown as "M1" [1]. Some cancers, such as blood cancers and brain and spinal cord tumours, have their own staging systems [1].

A cancer that has spread keeps the name of the original cancer: breast cancer that has reached the lungs is "stage 4 breast cancer" and is treated like breast cancer, not like lung cancer [2]. The stage given at diagnosis always stays the same, even if the cancer later grows or shrinks with treatment [1]. Read more: What are the stages of cancer? and What is metastasis and can it be treated?

Stage 3 vs stage 4 cancer: what is the difference?

In stage 3, the cancer is usually larger or has reached nearby tissues and lymph nodes, but it has not yet spread to distant organs; in stage 4, it has reached distant organs [1]. The difference shows in the chances of survival too: in the United States, for all cancers together, of every 10 people whose cancer had reached the lymph nodes or nearby tissues, about 7 were alive 5 years later; and of every 10 people whose cancer had spread to distant organs, 3 to 4 were [3].

Can stage 4 or advanced cancer be treated or cured?

Yes; there are treatments for most cancers that have spread [2]. Treatment at stage 4 has one of these three goals, and sometimes all three together:

Cure, in some cancers

A few cancers are often cured completely even when they have spread:

  • Testicular cancer: one of the most curable cancers even after it has spread [4]. In a study of nearly 10,000 men with non-seminoma testicular cancer that had spread and who received chemotherapy, more than 9 in 10 in the group with the best outlook, and even 2 in 3 in the group with the worst outlook, were alive 5 years later [4].
  • Advanced Hodgkin lymphoma: in a large study of adults up to the age of 60, almost everyone was alive 4 years later, and in more than 9 in 10 the disease had not come back or grown [5].
  • Bowel cancer that has spread only to the liver or lungs: if all the tumours can be removed with surgery, about 3 to 4 in 10 carefully selected patients are cured completely [6].

Long-term control

In many stage 4 cancers, the goal is often to stop or slow the growth of the cancer; some people live for years with cancer that is well controlled [2]. Targeted drugs and immunotherapy have made this time longer in many cancers [7, 8, 9].

Better quality of life and symptom control

Some treatments improve quality of life by easing symptoms such as pain. This is called "palliative care", and it can be given at any point during cancer treatment [2].

If the cancer has spread to only a few limited spots, treating those spots is sometimes possible [13]; read about this in What is metastasis? For the cancers with the best chance of cure, see also: Can cancer be cured?

Is stage 4 cancer terminal?

Not always. "Stage 4" tells you how far the cancer has spread; it does not tell you how long any one person will live [1, 2]. Some people live for years with cancer that has spread but is under control [2]. In the United States, the number of people who live for 5 years with cancer that has spread has almost doubled since the 1990s, and the greatest progress has been in lung cancer, melanoma, rectal cancer and stomach cancer [3].

Even so, the goal of treatment at stage 4 is often to control the disease rather than to get rid of it completely [2]; talking openly about this goal helps you make decisions that fit your own wishes. If the cancer no longer responds to treatment, many patients prefer care that focuses on comfort and peace; this, too, is a valuable treatment choice [3].

Stage 4 cancer life expectancy: how long can you live?

The answer is different for each type of cancer. For example, in the United States, about 4 in 10 people with prostate cancer that has spread, and about 3 to 4 in 10 with breast cancer or melanoma that has spread, are alive 5 years later; but 1 to 2 in 10 with bowel cancer, about 1 in 10 with lung cancer and fewer than 1 in 10 with stomach or liver cancer that has spread [3]. Within one type of cancer, too, the genetic features of the tumour and a treatment that matches them make a big difference [7, 8, 9]:

Examples from large studies in cancer that has spread
Cancer that has spreadTreatment in the studyWhat was shown
HER2-positive breast cancerTwo anti-HER2 drugs plus chemotherapyHalf of the patients lived for more than four and a half years; 8 years later, nearly 4 in 10 were alive [7]
Lung cancer with an EGFR mutationThe targeted tablet osimertinibHalf of the patients lived for more than 3 years [8]
MelanomaImmunotherapyWith nivolumab, half of the patients lived for more than 3 years, and with the combination of nivolumab and ipilimumab nearly 6 years; almost everyone whose disease had not progressed after 3 years had still not died of melanoma 10 years later [9]
Non-seminoma testicular cancerChemotherapyNearly 9 in 10 men were alive 5 years later; one of the most curable cancers after spread [4]

These figures describe large groups of patients and cannot predict what will happen to one person. "Half of the patients lived longer than …" means that the other half lived for a shorter time, and some for much longer.

That is why, before treatment starts, you should ask your doctor whether genetic testing of the tumour is needed for your cancer: What is targeted cancer therapy?, What is cancer immunotherapy? and Chemotherapy or targeted therapy? Read about the treatment of advanced disease for each cancer: HER2-positive breast cancer, hormone-receptor-positive breast cancer, EGFR-mutant lung cancer, Is lung cancer curable?, advanced melanoma, prostate cancer that has spread, advanced kidney cancer and MSI-H bowel cancer.

Palliative care from the start

Palliative care means easing pain and other symptoms and improving quality of life alongside cancer treatment; it is not only for the last days, and it can be given at any point during treatment [2]. In a study of patients newly diagnosed with lung cancer that had spread, those who received palliative care from the start alongside their usual treatment had a better quality of life and less depression; and although they received less intensive treatment in their last days, they also lived longer [10]. Ask your doctor to refer you to a palliative care or pain team. Read more: Cancer pain: it can be treated, do not put up with it and Anxiety, depression and fear of cancer coming back

What questions should I ask my oncologist?

  • What is the goal of my treatment: cure, long-term control or easing symptoms?
  • Do I need genetic testing of the tumour or any other test to choose my treatment?
  • What are the benefits of this treatment, and what side effects might it have? What happens if I do not have it?
  • How will we know whether the treatment is working, and how often will I be checked?
  • Who will help me with pain and other symptoms, and whom should I call at night or at weekends?
  • Is there a study I could take part in?

How much you want to know about statistics and your outlook is your choice; you can ask your doctor to tell you only what you want to know. Read more: What do cancer survival rates and life expectancy really mean? and A guide for families and carers of people with cancer

When should I call my doctor?

If you have cancer that has spread, do not wait for your next appointment in these situations:

  • New weakness or numbness in the legs, difficulty walking, or loss of control of your bladder or bowels: the cancer may be pressing on the spinal cord; this is an emergency and needs to be checked straight away [11].
  • New or worsening back pain, especially pain that gets worse when you cough, sneeze or strain, or that keeps you awake at night: tell your treatment team within 24 hours [11].
  • A temperature of 38°C or higher, chills or other signs of infection during chemotherapy: contact your treatment team at once [12].
  • New pain or pain that your current medicines do not ease [14], new breathlessness, confusion, or vomiting that stops you keeping down fluids and medicines.

In any emergency, such as severe breathlessness, chest pain or loss of consciousness, call your local emergency number.

Frequently asked questions

Can stage 4 cancer be cured?

In many cancers, the goal of treatment at stage 4 is long-term control rather than getting rid of the cancer completely [2]. But in a few cancers, such as testicular cancer and Hodgkin lymphoma, and in some people with bowel cancer that has spread only to the liver or lungs and can be removed with surgery, a cure is possible [4, 5, 6].

Is stage 4 cancer always fatal? Does it mean the last days of life?

Stage 4 is not the same as "the last days". Stage 4 only means that the cancer has reached distant parts of the body [1]; many patients live for years with cancer that is under control [2]. At the same time, stage 4 cancer is a serious illness; for example, in lung cancer that has spread, about 1 in 10 people are alive 5 years later [3].

Is chemotherapy or other treatment worth it at stage 4?

Yes; in many cancers that have spread, chemotherapy, targeted drugs and immunotherapy help people live longer [7, 8, 9], and some treatments ease symptoms [2]. Ask your doctor what the goal of treatment is in your case, and weigh up its benefits and side effects together. Read more: What are the side effects of chemotherapy?

If stage 4 cancer shrinks with treatment, does its stage go down?

No; the stage given at diagnosis always stays the same, even if the cancer changes later; new information is added to it [1]. If the cancer shrinks or disappears with treatment, your doctor will talk about a "response to treatment" or "remission".

For physicians

Key results in metastatic disease (for doctors)

For physiciansSpecialist table
For physicians
Disease and studyPopulationResult
Metastatic NSGCT (IGCCCG Update)9,728 men treated with first-line cisplatin-‎ and etoposide-based chemotherapy, 1990 to 20135-year OS: good prognosis 96%, intermediate 89% and poor 67% (overall 87%); 5-year PFS 90%, 78% and 54% (overall 78%); according to the authors, together with seminoma the most curable metastatic solid cancer in men [4]
Advanced classical Hodgkin lymphoma (HD21)1,500 adults aged up to 60; stage III or IV, or stage IIB with a large mediastinal mass or extranodal lesions4-year PFS 94.3% with BrECADD vs 90.9% with eBEACOPP (HR 0.66); 4-year OS 98.6% and 98.2% [5]
Resectable liver or lung metastases from colon cancerHighly selected patientsSurgery is curative in 25% to 40%; 5-year survival after negative-margin resection of liver metastases 25% to 40%, mostly in non-randomised studies [6]
HER2-positive metastatic breast cancer (CLEOPATRA)808 patients without previous treatment for metastatic disease, ECOG 0 or 1Pertuzumab plus trastuzumab and docetaxel: median OS 57.1 vs 40.8 months (HR 0.69); 8-year OS 37% vs 23% [7]
EGFR-mutant NSCLC (FLAURA)556 previously untreated patients, exon 19 deletion or L858RMedian OS 38.6 months with osimertinib vs 31.8 months with gefitinib or erlotinib (HR 0.80) [8]
Advanced melanoma (CheckMate 067)Previously untreated patients; minimum follow-up 10 yearsMedian OS: nivolumab plus ipilimumab 71.9, nivolumab 36.9 and ipilimumab 19.9 months; 10-year melanoma-specific survival in patients alive and progression-free at 3 years: 96%, 97% and 88% [9]
Early palliative care (Temel)151 patients with newly diagnosed metastatic NSCLCFACT-L 98.0 vs 91.5; depressive symptoms 16% vs 38%; aggressive end-of-life care 33% vs 54%; median survival 11.6 vs 8.9 months [10]

5-year relative survival for distant-stage disease in SEER (diagnosed 2015 to 2021): all cancers 35% (17% in 1995 to 1997); prostate 38%, melanoma 35%, breast 33%, ovary 32%, rectum 18%, colorectal 15%, lung 10% (2% in 1995 to 1997), stomach 8% and liver 3% [3].

Scientific evidence

Scientific evidence

7 items
Observational study

Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium

J Clin Oncol · 2021
96% (vs 92% in the original classification)5-year overall survival, good prognosis
Clinical trial · Phase 3

Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC

N Engl J Med · 2020
38.6 months vs 31.8 monthsMedian overall survival
Clinical trial · Phase 3

Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial

Lancet · 2024
42% vs 59%Treatment-related morbidity
Clinical trial · Phase 2

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

JCO · 2020
28 months vs 50 monthsMedian overall survival
Clinical trial

Early palliative care for patients with metastatic non-small-cell lung cancer

N Engl J Med · 2010
98.0 vs 91.5Quality of life at 12 weeks (FACT-L)
Clinical trial · Phase 3

Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma

N Engl J Med · 2025
71.9 / 36.9 / 19.9 monthsMedian overall survival
Clinical trial · Phase 3

Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer

N Engl J Med · 2012
18.5 months vs 12.4 months (pertuzumab group vs control)Median progression-free survival (independent assessment)

References

14 references
Show all references, 7 with a study cardClose the reference list

Numbers in the text, such as [1], refer to these sources. Sources with a “Study card” button are summarised in the site’s evidence library.

  1. 1
    Cancer StagingNational Cancer Institute · cancer.gov · 2022
    Source Back to text: 1 2 3 4 5 6 7 8 9
  2. 2
    Metastatic Cancer: When Cancer SpreadsNational Cancer Institute · cancer.gov · 2026
    Source Back to text: 1 2 3 4 5 6 7 8 9 10 11 12 13 14
  3. 3
    Cancer statistics, 2026Siegel RL, Kratzer TB, Wagle NS, et al · CA Cancer J Clin · 2026;76:e70043
    Study cardDOIPubMed Back to text: 1 2 3 4 5 6 7
  4. 4
    Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update ConsortiumGillessen S, Sauvé N, Collette L, et al · J Clin Oncol · 2021;39:1563-1574
    Study cardDOIPubMed Back to text: 1 2 3 4 5 6
  5. 5
    Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trialBorchmann P, Ferdinandus J, Schneider G, et al · Lancet · 2024;404:341-352
    Study cardDOIPubMed Back to text: 1 2 3 4
  6. 6
    Colon Cancer Treatment (PDQ®)–Health Professional VersionPDQ Adult Treatment Editorial Board · National Cancer Institute · 2025
    Source Back to text: 1 2 3
  7. 7
    Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 studySwain SM, Miles D, Kim SB, et al · Lancet Oncol · 2020;21:519-530
    DOIPubMed Back to text: 1 2 3 4 5 6
  8. 8
    Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLCRamalingam SS, Vansteenkiste J, Planchard D, et al · N Engl J Med · 2020;382:41-50
    Study cardDOIPubMed Back to text: 1 2 3 4 5 6
  9. 9
    Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced MelanomaWolchok JD, Chiarion-Sileni V, Rutkowski P, et al · N Engl J Med · 2025;392:11-22
    Study cardDOIPubMed Back to text: 1 2 3 4 5 6
  10. 10
    Early palliative care for patients with metastatic non-small-cell lung cancerTemel JS, Greer JA, Muzikansky A, et al · N Engl J Med · 2010;363:733-42
    Study cardDOIPubMed Back to text: 1 2 3
  11. 11
    Spinal metastases and metastatic spinal cord compression. NICE guideline NG234: RecommendationsNational Institute for Health and Care Excellence (NICE) · nice.org.uk · 2023
    Source Back to text: 1 2
  12. 12
    Infection and Neutropenia during Cancer TreatmentNational Cancer Institute · cancer.gov · 2020
  13. 13
    Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized TrialPalma DA, Olson R, Harrow S, et al · J Clin Oncol · 2020;38:2830-2838
  14. 14
    Pain and Cancer TreatmentNational Cancer Institute · cancer.gov · 2024

This page is based on reputable scientific sources and was last updated on 28 October 2026. The content of this website is for educational and informational purposes only and does not replace consultation, diagnosis or treatment by a specialist physician. Consult your treating physician about any treatment decision.